NCT01426802View on ClinicalTrials.gov

Vildagliptin 50 mg Twice Daily in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin

PHASE4CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

April 30, 2011

Study Completion Date

April 30, 2011

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

vildagliptin

Drug 50mg vildagliptin bid

Trial Locations (1)

Unknown

Investigative site, Cairo

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY